Has Wayne Shreffler received payments from drug or device companies?

Yes. Drug and device makers reported $51,508 in general payments to Wayne Shreffler across 44 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wayne Shreffler did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wayne Shreffler come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wayne Shreffler

Pediatric Allergy/Immunology · New York, NYNPI 1174592448

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $46,815 of the $51,508 with a category attached, or 90.9%. 9 manufacturers reported payments, led by Novartis at 28.8% of the total. Reporting peaked in 2021 at $21,525 and has fallen 81.3% since, to $4,016 in 2025. Among pediatric allergy/immunology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,508in general payments, 2019–2025

Across 44 payments — averaging $1170.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$15K
Genentech, Inc.$10K
GSK$7K
Aimmune Therapeutics, Inc.$6K
Merck$4K
Regeneron$3K
plus $7K from 3 others

$2,891,566in research payments, 2019–2025

Across 290 payments — averaging $9970.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Modernatx, Inc.$1.5M
Genentech, Inc.$648K
Regeneron$230K
Phadia US Inc.$198K
Novartis$180K
Aimmune Therapeutics, Inc.$81K
plus $75K from 4 others

What the payments were for

Consulting fees$46,81591%
Speaking & faculty fees$8002%
Travel & lodging$2,3395%
Food & beverage$1,5543%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	9	$14,819
Genentech, Inc.	5	$9,877
GSK	10	$7,312
Aimmune Therapeutics, Inc.	9	$5,720
Merck	1	$3,825
Regeneron	1	$3,163
Alk-abello, Inc	2	$2,800
Greer Laboratories, Inc.	1	$2,200
Genentech USA, Inc.	6	$1,793

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XOLAIR$21,934
DUPIXENT$3,163
PALFORZIA$2,673
NUCALA$645

How this compares

$51,508 in reported general payments places this provider in the 90th percentile of 51 pediatric allergy/immunology providers in New York.

See all pediatric allergy/immunology providers in New York →

Other pediatric allergy/immunology in New York

Jordan OrangeNew York$203K
Anna Nowak-WegrzynNew York$74K
Ramsay FuleihanNew York$68K
Julie WangNew York$14K
Joel BrooksNew York$13K
Hugh SampsonNew York$8K
Jacob KattanNew York$6K
Nicole RamseyNew York$5K
Amanda CoxNew York$3K
Lisa MorenoNew York$2K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →